Why Is Tesla Stock Falling?
Tesla stock reached an all-time high of $479.86 on December…
Buy
53
CAH Quote, Financials, Valuation and Earnings
Last price:
$126.19
Seasonality move
:
1.98%
Day range:
$126.16 - $127.90
52-week range:
$93.17 - $132.84
Dividend yield:
1.6%
P/E ratio:
23.55x
P/S ratio:
0.14x
P/B ratio:
--
Volume:
1.6M
Avg. volume:
2.4M
1-year change:
21.88%
Market cap:
$30.5B
Revenue:
$226.8B
EPS (TTM):
$5.36
Analysts' Opinion
-
Consensus RatingCardinal Health has received a consensus rating of Buy. The company's average rating is a Buy based on 9 Buy ratings, 6 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $140.67, Cardinal Health has an estimated upside of 11.46% from its current price of $126.21.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $108.11 representing 14.34% downside risk from its current price of $126.21.
Fair Value
-
According to the consensus of 15 analysts, Cardinal Health has 11.46% upside to fair value with a price target of $140.67 per share.
CAH vs. S&P 500
-
Over the past 5 trading days, Cardinal Health has underperformed the S&P 500 by -2.35% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Cardinal Health does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Cardinal Health revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Cardinal Health reported revenues of $55.3B.
Earnings Growth
-
Cardinal Health has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Cardinal Health reported earnings per share of $1.65.
Enterprise value:
34.4B
EV / Invested capital:
--
Price / LTM sales:
0.14x
EV / EBIT:
18.23x
EV / Revenue:
0.15x
PEG ratio (5yr expected):
0.21x
EV / Free cash flow:
-70.69x
Price / Operating cash flow:
29.24x
Enterprise value / EBITDA:
13.10x
Gross Profit (TTM):
$7.6B
Return On Assets:
2.88%
Net Income Margin (TTM):
0.59%
Return On Equity:
--
Return On Invested Capital:
53.16%
Operating Margin:
0.96%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $193B | $216B | $222.2B | $57.4B | $55.3B | |
| Gross Profit | $6.5B | $7.2B | $7.6B | $1.9B | $1.9B | |
| Operating Income | $1.6B | $2.1B | $2.2B | $523M | $530M | |
| EBITDA | $614M | $1.9B | $2.6B | $690M | $738M | |
| Diluted EPS | -$4.65 | $2.54 | $5.36 | $1.50 | $1.65 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $30.1B | $31.8B | $34.6B | $37.7B | $35.8B | |
| Total Assets | $44.7B | $43.7B | $44.5B | $46.6B | $47B | |
| Current Liabilities | $25.8B | $27.7B | $33.2B | $38.3B | $35.2B | |
| Total Liabilities | $42.7B | $42.7B | $46.7B | $50B | $49.9B | |
| Total Equity | $2B | $1B | -$2.2B | -$3.4B | -$2.9B | |
| Total Debt | $6.7B | $5.6B | $5.3B | $4.7B | $7.6B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $3.2B | $3.9B | $8M | $1.2B | -$400M | |
| Cash From Investing | -$405M | -$465M | -$2.7B | -$105M | -$976M | |
| Cash From Financing | -$2.3B | -$2.5B | $2B | -$353M | $2.3B | |
| Free Cash Flow | $2.8B | $3.4B | -$486M | $1.1B | -$499M | |
CAH
Sector
Market Cap
$30.5B
$43.4M
Price % of 52-Week High
95.01%
48.26%
Dividend Yield
1.6%
0%
Shareholder Yield
1.02%
-0.75%
1-Year Price Total Return
21.88%
-34.26%
Beta (5-Year)
0.630
0.749
Dividend yield:
1.6%
Annualized payout:
$1.50
Payout ratio:
37.71%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$127.19
200-day SMA
Buy
Level
$110.47
Bollinger Bands (100)
Buy
Level
112.81 - 125.15
Chaikin Money Flow
Buy
Level
528.3M
20-day SMA
Sell
Level
$127.36
Relative Strength Index (RSI14)
Buy
Level
51.91
ADX Line
Buy
Level
39.19
Williams %R
Neutral
Level
-66.3996
50-day SMA
Buy
Level
$123.01
MACD (12, 26)
Buy
Level
1.06
25-day Aroon Oscillator
Buy
Level
48
On Balance Volume
Neutral
Level
237.9M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (5.3875)
Sell
CA Score
(Annual)
Level (-0.936)
Buy
Beneish M-Score
(Annual)
Level (-2.6731)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (2.2255)
Buy
Piotroski F Score
(Annual)
Level (6)
Sell
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Cardinal Health is one of three leading pharmaceutical wholesalers in the us, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the us pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Stock Forecast FAQ
In the current month, CAH has received 9 Buy ratings 6 Hold ratings, and 0 Sell ratings. The CAH average analyst price target in the past 3 months is $140.67.
-
Where Will Cardinal Health Stock Be In 1 Year?
According to analysts, the consensus estimate is that Cardinal Health share price will rise to $140.67 per share over the next 12 months.
-
What Do Analysts Say About Cardinal Health?
Analysts are divided on their view about Cardinal Health share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Cardinal Health is a Sell and believe this share price will drop from its current level to $108.11.
-
What Is Cardinal Health's Price Target?
The price target for Cardinal Health over the next 1-year time period is forecast to be $140.67 according to 15 Wall Street analysts, 9 of them rate the stock a Buy, 0 rate the stock a Sell, and 6 analysts rate the stock a Hold.
-
Is CAH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Cardinal Health is a Buy. 9 of 15 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of CAH?
You can purchase shares of Cardinal Health via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Cardinal Health shares.
-
What Is The Cardinal Health Share Price Today?
Cardinal Health was last trading at $126.19 per share. This represents the most recent stock quote for Cardinal Health. Yesterday, Cardinal Health closed at $126.21 per share.
-
How To Buy Cardinal Health Stock Online?
In order to purchase Cardinal Health stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is DoorDash a Buy, Sell or Hold?
Gig economy food delivery service DoorDash (NASDAQ:DASH) has been running…
Is Clorox’s Dividend Worth It?
Clorox (NYSE:CLX) is the parent company of some of the…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
61
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 116x
Sell
47
Is MSFT Stock a Buy?
Market Cap: $3T
P/E Ratio: 35x
Alerts
Buy
87
PCOR alert for Feb 15
Procore Technologies [PCOR] is up 16.3% over the past day.
Buy
54
DKNG alert for Feb 15
DraftKings [DKNG] is up 15.24% over the past day.
Sell
30
TWLO alert for Feb 15
Twilio [TWLO] is down 15.01% over the past day.
